#USA #Cambridge #LabCentral #biotech #Ajinomoto

Ajinomoto Partners with LabCentral to Boost Biotech Innovation

Ajinomoto Co., Inc., a renowned global leader in biotechnology and culinary innovation, has recently unveiled its Gold sponsorship of LabCentral, a prestigious incubator that fosters innovative biotech startups. Situated in the heart of the thriving Boston biotech ecosystem, LabCentral plays a crucial role in nurturing startups that seek to make significant advancements in the life sciences.

This partnership reflects Ajinomoto's unwavering commitment to innovation, scientific progress, and collaboration in this dynamic field. The company aims to pioneer advancements through its commitment to "AminoScience," leveraging cutting-edge technologies in areas like cell and gene therapy, amino acids, and protein sciences. Ajinomoto's strategy development team is particularly focused on empowering the growing biotech community in Cambridge and across Massachusetts.

LabCentral offers luxurious lab spaces, vital resources, and a collaborative community designed to transform groundbreaking ideas into commercially viable solutions. By partnering with LabCentral, Ajinomoto will enhance LabCentral's capacity to support exciting ventures in drug discovery, cell and gene therapy, and other transformational life sciences sectors.

"LabCentral exemplifies the unbreakable link between innovation and opportunity in the biotechnology landscape," said Dr. Ikuo Kira, Executive Director, and General Manager of Ajinomoto's North America Division. "Our sponsorship showcases our dedication to advancing cutting-edge research and providing innovators with the resources they need to thrive."

Johannes Fruehauf, the CEO and co-founder of LabCentral, expressed appreciation for Ajinomoto's commitment, remarking, "We are excited to welcome Ajinomoto as a Gold sponsor of LabCentral. Their expertise in various biotechnology fields, particularly cell and gene therapies, will greatly benefit our resident startups and the broader Massachusetts biotech ecosystem."

Through this collaboration, Ajinomoto aims to engage with pioneering biotech entrepreneurs, utilizing its technological expertise and resources to accelerate their development journey. This significant alliance not only showcases Ajinomoto's support for innovation but also highlights its desire to contribute to improving human well-being and sustainability through science.

For additional details on Ajinomoto and its initiatives, visit Ajinomoto Innovation. To learn more about LabCentral, check out LabCentral's Website.

About Ajinomoto Health & Nutrition North America, Inc.

Ajinomoto Health & Nutrition North America, Inc., a wholly-owned subsidiary of Ajinomoto Group, boasts vast experience in researching, developing, manufacturing, and selling amino acid-based products for multiple industries, including pharmaceuticals, nutraceuticals, wellness, and food ingredients. Since opening its first US office in New York in 1917, Ajinomoto has continuously expanded its presence across various states, including North Carolina, Iowa, and Illinois, providing high-quality products through its comprehensive global supply chain.

About LabCentral

Founded in 2013, LabCentral is a non-profit institution serving as a launchpad for high-potential startups in life sciences and biotechnology, with over 243,000 square feet of lab space located in Kendall Square, Cambridge, and the Harvard University campus. LabCentral fosters a complete package of programming and networking for life sciences entrepreneurs, complemented by licensed laboratories and offices for startups either in their early stages or already growing. For more information about LabCentral, visit LabCentral.

For media inquiries, contact Andrea Rodriguez at [email protected]